EUVIMEDEUVIMED entdecken
Crossref

Chiral Aluminum Oxyhydroxide Supraparticles as Adjuvants

Zongda Li, Aihua Qu, Chuanlai Xu iD, Hua Kuang, Liguang Xu, Maozhong Sun

Advanced Materials · 2025

DOI: 10.1002/adma.202504458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Zongda Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: International Joint Research Laboratory for Biointerface and Biodetection, State Key Laboratory of Food Science and Technology, School of Food Scienc…. Hauptthemen laut MEDLINE: Aluminum Hydroxide, Adjuvants, Immunologic, Nanoparticles. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aluminum‐based adjuvants dominate global vaccine formulations owing to their proven efficacy in humoral immunity induction. However, their inherent limitations in activating cellular immunity pose critical challenges for vaccine development. In this study, chiral flower‐like aluminum oxyhydroxide (AlOOH) supraparticles (SPs) are synthesized via a one‐pot hydrothermal method using cysteine (Cys) enantiomers as chiral ligands, achieving a g‐factor of 0.004. L‐AlOOH SPs (L‐SPs) demonstrate significantly greater enhancement in dendritic cell (DC) maturation and antigen cross‐presentation efficiency compared to D‐AlOOH SPs (D‐SPs), indicating its potential as an adjuvant. Mechanistic studies reveal that L‐SPs enter DCs via Toll‐like receptor 2 (TLR2), thereby enhancing NOD‐like receptor thermal protein domain associated protein 3 (NLRP3) inflammasome activation. In vivo experiments show that L‐SPs generate 21.59‐fold higher OVA‐specific antibody titers than commercial aluminum adjuvants. Further studies show that L‐SPs, after mixed with H9N2 virus proteins, enhance influenza virus antibody titers by 15.28‐fold, with sustained protection, confirming its translational potential. This study demonstrates the performance of chiral AlOOH SPs to simultaneously amplify humoral and cellular immunological responses, entering it as a promising next‐generation adjuvant for cancer immunotherapy and pandemic preparedness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aluminum HydroxideAdjuvants, ImmunologicNanoparticlesAnimalsMiceDendritic CellsNLR Family, Pyrin Domain-Containing 3 ProteinCysteineMice, Inbred C57BLStereoisomerismInflammasomesHumansToll-Like Receptor 2Aluminum Oxide

Stichwörter der Autor:innen

adjuvantaluminum oxyhydroxide supraparticleschiralimmunological responsevirus

Substanzen

Aluminum HydroxideAdjuvants, Immunologicaluminum oxide hydroxideNLR Family, Pyrin Domain-Containing 3 ProteinCysteineInflammasomesToll-Like Receptor 2Aluminum Oxide

Autor:innen und Institutionen

  • International Joint Research Laboratory for Biointerface and Biodetection, State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, 214122, China.

ORCID-Profile: Chuanlai Xu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • National Key R&D Program of China
  • National Key Research and Development Program of China

Zitieren

APA

Li, Z., Qu, A., Xu, C., Kuang, H., Xu, L., & Sun, M. (2025). Chiral Aluminum Oxyhydroxide Supraparticles as Adjuvants. Advanced Materials. https://doi.org/10.1002/adma.202504458

Vancouver

Li Z, Qu A, Xu C, Kuang H, Xu L, Sun M. Chiral Aluminum Oxyhydroxide Supraparticles as Adjuvants. Advanced Materials. 2025. doi:10.1002/adma.202504458

BibTeX
@article{Li2025,
  author = {Li, Zongda and Qu, Aihua and Xu, Chuanlai and Kuang, Hua and Xu, Liguang and Sun, Maozhong},
  title = {Chiral Aluminum Oxyhydroxide Supraparticles as Adjuvants},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202504458}
}
Kostenlos starten →